Pharmaniaga seeks the right medicine


Pharmaniaga Bhd managing director Zulkifli Jaafar. — AZLINA ABDULLAH/The Star

IT’s been two years since Pharmaniaga Bhd slipped into Practice Note 17 (PN17) status.

Will the company’s regularisation plan – recently approved by Bursa Malaysia – be able to lift it out of its doldrums?

Follow us on our official WhatsApp channel for breaking news alerts and key updates!
Pharmaniaga , PN17 , Vaccine , Insulin , Healthcare , Biopharma

Next In Business News

Merdeka 118 Community Grants backs nine projects under Cycle 3
Trump hikes US global tariff rate to 15%
The parcel overhang
Zero abandoned homes�by�2030?
Unmasking housing market pricing abuses
Ringgit likely to trade cautiously next week ahead of key US data
Powering a new reinvestment cycle as demand surges
Up in Arms - or up the value chain?
Asia bonds for diversification
AI disruption fears rock markets

Others Also Read